--- title: CDMOs offering Process Development with Oligonucleotide path: /explore/process-development/oligonucleotide companies_count: 27 --- # CDMOs offering Process Development with Oligonucleotide 27 published CDMOs match Process Development and Oligonucleotide. Locations in this set include United States, Switzerland, United Kingdom, Canada, China, and Japan. Capabilities that show up most often in this set: CMC Analytical Development, Oligonucleotide Manufacturing, Technology Transfer, CMC Regulatory Submission Support, and Formulation Development. ## Matching companies - [AXOlabs](/companies/axolabs) - Integrated CRO and CDMO specializing in nucleic acid therapeutics (ASOs, siRNA, sgRNA, aptamers) from lead identification through GMP manufacturing, with dual-site facilities in Petaluma, USA and Berlin, Germany. - [Ajinomoto Bio-Pharma Services](/companies/ajibio-pharma) - Ajinomoto Bio-Pharma Services is a global contract development and manufacturing organization (CDMO) dedicated to improving the health of humankind through adaptive solutions and responsive service. - [Almac Group](/companies/almacgroup) - Global CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities. - [Asymchem Laboratories](/companies/asymchem) - Asymchem is a CDMO providing integrated API synthesis, drug product development, and biologics manufacturing with specialized capabilities in peptides, oligonucleotides, highly potent compounds, and flow chemistry. - [BOC Sciences](/companies/boc-sciences) - BOC Sciences is a custom lab chemical supplier offering bulk compounds, custom synthesis, cGMP manufacturing, analytical services, and specialized drug delivery and bioconjugation platforms for pharmaceutical and biotechnology clients. - [BSP Pharmaceuticals](/companies/bsppharmaceuticals) - BSP Pharmaceuticals is a CDMO specializing in development and manufacturing of cytotoxic oncology drugs, ADCs, peptides, proteins, and lipid-based formulations from preclinical GLP through commercial supply. - [Bachem](/companies/bachem) - Global leader in peptide and oligonucleotide development and manufacturing, offering GMP-compliant clinical and commercial supply from early research through commercial scale. - [BioVectra](/companies/biovectra) - North American CDMO specializing in clinical-to-commercial biologics, small molecules, HPAPIs, and bioreagents with 50+ years of microbial fermentation and complex chemistry expertise across cGMP facilities in Canada. - [Biospring](/companies/biospring) - Global CDMO leader in nucleic acid manufacturing and analysis (mRNA, ASO, siRNA, guide RNA, oligonucleotides) with nearly three decades of expertise, GMP certification since 2007, and support for 9 commercial programs across all clinical phases. - [CDMO Network](/companies/cdmonetwork) - CDMO Network is a biomanufacturing partner-routing platform that connects biotech sponsors with specialized CDMO partners across modalities, development stages, and geographies to reduce integration friction and accelerate program execution. - [CPC Scientific](/companies/cpcscientific) - CPC Scientific provides GMP peptide and oligonucleotide manufacturing for Phase I through commercial programs, plus custom synthesis and FTE services for research applications. - [CordenPharma](/companies/cordenpharma) - Full-service CDMO offering cGMP development and manufacturing of APIs, lipid excipients, drug products, injectables, peptides, LNPs, oligonucleotides, and oral solid dose across 10 facilities in 6 countries with 3000+ employees. - [Dalton Pharma Services](/companies/dalton) - Health Canada–approved and FDA-inspected cGMP contract manufacturer offering integrated drug discovery, development, and manufacturing services including custom synthesis, API production, formulation development, and sterile fill-finish for vials, syringes, and cartridges. - [Fujifilm Pharmaceuticals U.S.A., Inc](/companies/fujifilmpharma) - CDMO specializing in liposome and lipid nanoparticle (LNP) formulation development and GMP manufacturing from bench to commercial scale, with mRNA process development and aseptic fill-finish capabilities. - [Galenvs Sciences](/companies/galenvs-sciences) - Galenvs makes modified, specialty oligonucleotides for drug and gene-therapy programs, from proof of concept to pilot scale, under an ISO 9001:2015 certified quality system. - [Global Biotech Laboratories](/companies/globalbiotechlaboratories) - Global Biotech Laboratories is a peptide and oligonucleotide CDMO offering end-to-end contract development and manufacturing from route scouting through validated commercial supply, with cGMP and ICH Q7 compliance across manufacturing sites on three continents. - [Hongene Biotech Corporation](/companies/hongene) - Hongene is a vertically-integrated CDMO offering end-to-end oligonucleotide and mRNA manufacturing from raw materials to GMP drug product, with nearly 30 years of RNA-focused expertise and tonne-scale production capacity. - [Maravai LifeSciences](/companies/maravai) - Leading provider of nucleic acid products, custom enzymes, and bioprocess analytics supporting vaccine, therapeutic, and diagnostic development from discovery through commercialization, with mRNA CDMO services including proprietary CleanCap® capping technology. - [PharmaBlock](/companies/pharmablock) - Leading provider of innovative chemistry products and services for pharmaceutical R&D and commercial manufacturing, with expertise in process development, GMP manufacturing, and low-carbon chemistry solutions. - [Pharmaron](/companies/pharmaron) - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.